GILO Institute

Gilo Biotech is an Israeli biotechnology company focused on developing novel therapeutic solutions for metabolic disorders, specifically obesity and type 2 diabetes. The company's approach centers on the identification and extraction of bioactive compounds from the Gilo plant (Solanum aethiopicum), which has traditional uses in managing weight and blood sugar. Gilo Biotech aims to standardize these extracts into pharmaceutical-grade treatments that can effectively regulate metabolism with a favorable safety profile. Their research is primarily in the pre-clinical stage, exploring the mechanisms by which these plant-derived molecules influence adipogenesis and glucose homeostasis.